News | December 05, 2014

Interventional Radiology Procedure Preserves Uterus in Patients with Placenta Accreta

Incidence of placenta accreta expected to climb in the future

interventional radiology, placenta accreta, RSNA, study

December 5, 2014 — Researchers reported on a procedure that can preserve fertility and potentially save the lives of women with a serious pregnancy complication called placenta accreta. Results of the new study presented at the annual meeting of the Radiological Society of North America (RSNA) showed that placement of balloons in the main artery of the mother's pelvis prior to a Caesarean section protects against hemorrhage and is safe for both mother and baby.

Placenta accreta, a condition in which the placenta abnormally implants in the uterus, can lead to additional complications, including massive obstetric hemorrhage at delivery. Surgical removal of the uterus, called hysterectomy, is commonly required to control such bleeding.

"Massive obstetric hemorrhage is the No. 1 cause of maternal mortality worldwide and abnormal placental implantation is a major risk factor for this," said Patrick Nicholson, M.B., B.Ch., an interventional radiologist trainee at Cork University Hospital in Cork, Ireland.

At Nicholson's hospital, patients with abnormal placental implantation are treated by a multidisciplinary team that plans both an elective C-section and prophylactic internal iliac balloon placement under fluoroscopic guidance. Immediately prior to the patient's C-section, an interventional radiologist uses specialized techniques to insert balloons into the two internal iliac arteries in the pelvis that supply the uterus with blood flow.

"Following the delivery of the baby, these balloons can be inflated to slow blood flow to the uterus, which allows the obstetrician time to gain control of the hemorrhage," Nicholson said.

For his study, Nicholson retrospectively reviewed the charts of all patients with abnormal placental implantation who received prophylactic internal iliac balloon placement since 2009. Over a 44-month period, the hospital treated 21 patients (mean age 35) who underwent balloon placement immediately followed by C-section.

In 13 of the 21 deliveries, the arterial balloons were inflated and when no longer needed, deflated and removed from the patient. The interventional radiology procedure was a technical success in 100 percent of the cases. However, despite use of the balloons, two of the patients required a hysterectomy.

"Without the balloons, many more of the patients would likely have required a hysterectomy," Nicholson said.

There were no maternal or fetal complications resulting from the interventional procedure.

"We are the first group to report on the fetal outcomes associated with prophylactic internal iliac artery balloon placement," Nicholson said. "There were no adverse outcomes for the babies as a result of this procedure."

According to Nicholson, the incidence of abnormal placental implantation has been increasing steadily over recent years.

"The risks for placenta accreta and its variations increase with a woman's age, previous C-sections and in vitro fertilization, all of which we expect to see more of in the coming decades," he said. "There's clearly a need for more research in this field."

Nicholson said results of the study add to a growing body of evidence that high-risk placental implantation pregnancies are best managed in a multidisciplinary setting.

"This research highlights the value of interventional radiology in managing this very serious, high-risk condition to control bleeding and maternal and fetal complications," Nicholson said.

For more information: www.rsna.org

Related Content

The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Philips Debuts Integrated Breast Ultrasound Solution
News | Ultrasound Women's Health | October 26, 2018
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq...
Etta Pisano Named American College of Radiology Chief Research Officer
News | Radiology Business | October 25, 2018
October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...
DenseBreast-info.org Launches Patient Education Video Series
News | Breast Density | October 24, 2018
DenseBreast-info.org (DB-I) announced the release of "Let's Talk About Dense Breasts," a series of three informational...